This website uses own and third party cookies to give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Accept More information




Publications<< Back

Sabaté M, Brugaletta S, Abizaid A, Banning A, Bartorelli A, Džavík V, Ellis S, Holmes D, Gao R, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

Int. J. Cardiol.. 2013 Oct;168(3):2522-7, PMID: 23602865

Outcome of sirolimus-eluting stent (SES) in patients treated with an antivitamin K (VKA) agent before the PCI procedure is unknown.

CARDIAC & CARDIOVASCULAR SYSTEMS

Download publication

An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar